<DOC>
	<DOCNO>NCT01347879</DOCNO>
	<brief_summary>This study intend evaluate efficacy safety Visonac Photodynamic Therapy ( PDT ) patient severe acne , score 4 global IGA scale . The null hypothesis Visonac PDT equal vehicle PDT alternative hypothesis Visonac PDT different compare vehicle PDT week 12 .</brief_summary>
	<brief_title>A Double Blinded , Prospective , Randomized , Vehicle Controlled Multi-center Study Photodynamic Therapy With VisonacÂ® Cream Patients With Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Female male patient , 1235 year age severe facial acne vulgaris ( IGA score 4 IGA scale ) Signed verify informed consent form photo consent form . For subject age 18 , assent form conjunction inform consent form , sign verified parent/guardian . Female patient surgically sterile , premenstrual , postmenopausal , abstinent , willing use adequate mean contraception include birth control pill , barrier method spermicide least 14 day prior T1 . Patients use birth control pill must use product dose least 3 month must agree stay product dose additional 3 month . Fitzpatrick skin type I VI , Patients 25 75 inflammatory lesion ( papule , pustule , nodule ) face . Patients 20 100 noninflammatory lesion ( open close comedo ) face . Patients acne conglobata , acne fulminans , secondary acne ( chloracne , druginduced acne , etc . ) Patients 3 nodule face . Patient investigator sub investigator , research assistant , pharmacist , study coordinator , staff relative thereof directly involve conduct study . Patients unlikely comply protocol , e.g . mental condition render patient unable understand nature , scope , possible consequence clinical study , uncooperative attitude unlikelihood complete study ( e.g . drug alcohol abuse ) . Female patient childbearing potential ( i.e . ovulation , premenopausal , surgically sterilize ) sexually active , willing use medically accept contraceptive regimen ( describe inclusion criterion ) treatment . Pregnancy . Nursing . Participation clinical study either currently within last 30 day . Patients porphyria . Patients cutaneous photosensitivity . Known allergy MAL , similar PDT compound , excipients cream Patients use testosterone , systemic hormonal treatment hormonal contraceptive solely control acne . Patients receive topical treatment facial acne within last 14 day ( e.g steroid , retinoids , glycolic acid , benzoyl peroxide , anti inflammatory agent , antibiotic ) . Medicated cleanser may use washout period stop treatment . Patients receive oral antibiotic treatment acne within last month . Patients receive oral isotretinoin within last 6 month . Patient receive facial procedure like dermabrasion , chemical laser peel within last 1 month . Patients use testosterone , systemic hormonal treatment reason acne treatment product dose least 3 month Patients moderate , severe severe facial acne scar accord scar scale describe section 10.4.3 . Patients beard might interfere study assessment . Patients melanoma dysplastic nevus treatment area . Exposure ultraviolet radiation ( UVB phototherapy , sun tan salon ) within last 30 day Exposure PDT within 12 week T1 .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Acne vulgaris</keyword>
	<keyword>PDT</keyword>
</DOC>